|
Nonlinear Mixed Effects Modeling of Rifapentine in Children |
Kenya; South Africa; China; Viet Nam; Peru |
Tuberculosis, Pediatrics |
|
|
|
Clinical Trial Simulation efforts for upcoming HIV therapeutic development. |
United States |
HIV/AIDS |
|
|
|
Nonlinear Mixed Effects Modeling of Rifapentine Pharmacokinetics |
Uganda |
Tuberculosis, Pharmacology and Drug Treatment |
|
|
|
Pharmacostatistical Modeling and Simulation of Randomized Clinical PrEP Trials |
United States |
HIV/AIDS, Systematic Reviews and Guideline Development, Treatment Adherence |
|
|
|
Biostatistical analysis of Mycobacterium Tuberculosis Biomarkers for Diagnosis and Cure |
United States |
Tuberculosis, Drug and Diagnostics Development |
|
|
|
Multiscale System Pharmacology Disease Platform for Tuberculosis |
United States |
Tuberculosis |
|
|
|
Optimal MDR treatment in children |
Indonesia |
Tuberculosis, Pediatrics |
|
|
|
Lesion-centric imaging and PK-PD of pyrazinamide for TB/HIV co-infection |
United States |
Tuberculosis |
|
|
|
Impact of Pregnancy on Tuberculosis |
India |
Tuberculosis, Women's Health, Labor and Delivery, Newborn and Infant Health |
|
|
|
Mechanism-Based Integrative Pharmacology Model for Tuberculosis |
United States |
Tuberculosis, Pharmacology and Drug Treatment |
|
|
|
Integrative Pharmacology Approach to Understand Mechanisms of Tuberculosis Drug Resistance |
United States |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development |
|
|
|
De Facto Monotherapy during Multidrug Tuberculosis Treatment and Emergence of Resistance |
United States |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis |
|
|
|
Phase III Quinolone Meta-Analysis |
United States |
Drug and Diagnostics Development |
|
|
|
Development of Rectal Enema As Microbicide (DREAM) |
United States |
HIV/AIDS, Pharmacology and Drug Treatment |
|
|
|
Optimal MDR treatment in children |
South Africa |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis |
|
|
|
Adherence Monitoring impact in Global Health - Planning Grant |
Uganda |
Tuberculosis, Treatment Adherence |
|
|
|
Impact of Pregnancy on Tuberculosis |
Uganda |
Tuberculosis, Pharmacology and Drug Treatment, Women's Health, Labor and Delivery, Newborn and Infant Health |
|
|
|
Novel Biomarkers to Shorten TB Treatment |
United States |
Tuberculosis |
|
|
|
Lesion Drug Penetration and Translational Modeling |
United States |
Tuberculosis, Drug and Diagnostics Development |
|
|
|
Identifying Optimal Treatment Strategies for Tuberculosis Treatment |
Kenya; Malawi; Uganda; Zimbabwe; South Africa; China; India; Viet Nam; Thailand; Brazil; Peru; Haiti |
Tuberculosis, Pharmacology and Drug Treatment |
|
|
